L. Lassel
Impact in
- Biotechnology top 2%
- Listeria monocytogenes in Food Safety
- Microbiology top 5%
- Bacterial Infections and Vaccines
Papers in
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- Antimicrobial Resistance in Staphylococcus 2
- Tuberculosis Research and Epidemiology 2
-
- Hepatitis C virus research 2
- Co-authors
- Gilles Pialoux (12 shared papers)François Durand (1 shared paper)B. Fantin (1 shared paper)Frédéric Bert (1 shared paper)Jacques Belghiti (1 shared paper)France Mentré (1 shared paper)Pierre‐Marie Girard (1 shared paper)Fabien Lavocat (1 shared paper)
- Journals
- International Journal of Infectious Diseases (2 papers)The Lancet Infectious Diseases (2 papers)Journal of Infection (2 papers)The Lancet (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- FranceGreeceUnited States
In The Last Decade
L. Lassel
29 papers receiving 778 citations
L. Lassel's Hit Papers
Peers
Comparison fields: 5 of 71
- Biotechnology 244
- Microbiology 99
- Infectious Diseases 208
- Molecular Medicine 47
- Microbiology 4
Countries citing papers authored by L. Lassel
This map shows the geographic impact of L. Lassel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lassel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lassel more than expected).
Fields of papers citing papers by L. Lassel
This network shows the impact of papers produced by L. Lassel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lassel. The network helps show where L. Lassel may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Lassel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 397 |
| 2 | 2023 | 63 | |
| 3 | 2005 | 53 | |
| 4 | 2012 | 43 | |
| 5 | 2020 | 40 | |
| 6 | 2009 | 28 | |
| 7 | 2015 | 28 | |
| 8 | 2023 | 25 | |
| 9 | 2013 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 17 | |
| 12 | 2025 | 17 | |
| 13 | 2008 | 16 | |
| 14 | 2008 | 6 | |
| 15 | 2021 | 6 | |
| 16 | 2025 | 6 | |
| 17 | 2012 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About L. Lassel
L. Lassel is a scholar working on Infectious Diseases, Hepatology, Epidemiology, Internal Medicine and Public Health, Environmental and Occupational Health, having authored 35 papers that have together received 811 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Mosquito-borne diseases and control (3 papers), Infectious Diseases and Tuberculosis (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Hepatitis C virus research (2 papers), Pneumonia and Respiratory Infections (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Biotechnology (244 citations), Microbiology (99 citations), Infectious Diseases (208 citations), Molecular Medicine (47 citations) and Microbiology (4 citations). L. Lassel has collaborated with scholars based in France, Greece and United States. Frequent co-authors include Gilles Pialoux, François Durand, B. Fantin, Frédéric Bert, Jacques Belghiti, France Mentré, Pierre‐Marie Girard, Fabien Lavocat, Karine Lacombe and Constance Delaugerre. Their work appears in journals such as International Journal of Infectious Diseases, The Lancet Infectious Diseases, Journal of Infection, The Lancet and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.